Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05575141
Other study ID # ROCSTAR
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date March 1, 2029

Study information

Verified date October 2022
Source Algemeen Ziekenhuis Maria Middelares
Contact Maaike Vierstraete, MD
Phone +3292467400
Email maaikevierstraete@icloud.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date March 1, 2029
Est. primary completion date January 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients with a ventral incisional hernia of more than 8 centimeters in width Exclusion Criteria: - Emergency surgery - Pregnancy - Age<18 - Incisional hernia repair after open abdomen or enterocutaneous fistula - Active wound infection - Previous anterior or posterior component separation - Absence of a signed informed consent - Patients unable to give informed consent or complete the quality-of-life assessment (due to language barriers or intellectual capacity) - Primary ventral hernias

Study Design


Intervention

Procedure:
Component separation (transversus abdominis release)
Component separation by transversus abdominis release, to allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Algemeen Ziekenhuis Maria Middelares

Outcome

Type Measure Description Time frame Safety issue
Primary Length of postoperative hospital stay Length of postoperative hospital stay From date of operation until the date of discharge, assessed up to 20 days
Secondary Skin-to-skin operative time Skin-to-skin operative time Per-operative (minutes)
Secondary Conversion rate Conversion rate Per-operative
Secondary Postoperative complication rate Surgical site infection - surgical site occurrence - surgical site occurrence requiring procedural interventions 30 days
Secondary Readmission and reoperation rate Readmission and reoperation rate 30 Days
Secondary Post-anesthetic discharge scoring system Minimum score is 0, maximum score is 12. The higher the score, the better the outcome. Immediately after the surgery
Secondary Postoperative visual analogue scale pain score Minimum score is 0, maximum score is 10. The higher the score, the worse the outcome. Immediately after the surgery
Secondary Quality of Life Scoring Minimum score is 0, maximum score is 90. The higher the score, the worse the outcome. Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
Secondary Body image score Minimum score is 0, maximum score is 10. A higher score means a higher level of body image disturbance (worse outcome). Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
Secondary Hernia recurrence Hernia recurrence 3 Months, 12 months, 24 months, 60 months
Secondary Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence 3 Months, 12 months, 24 months, 60 months
See also
  Status Clinical Trial Phase
Terminated NCT03034213 - Gentrix™ Versus Biological or Prosthetic Mesh N/A
Enrolling by invitation NCT06306976 - Shear-Wave Elastography N/A
Not yet recruiting NCT06183840 - Only Mesh Fixation With Glue of Ventral/Incisional Laparoscopic Hernia Repair N/A
Completed NCT02206828 - The SymCHro - Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair
Not yet recruiting NCT04624100 - Quality Control of Ventral Hernia Surgery by Prospective Registration
Active, not recruiting NCT03324854 - Use of Mosquito Net Mesh for Ventral Hernia Repair N/A
Completed NCT01325792 - Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement N/A
Terminated NCT03317665 - Observational Biologic or Prosthetic Mesh
Recruiting NCT05576753 - Preperitoneal Umbilical Mesh Area N/A
Completed NCT05142761 - Tension in Posterior Component Separation for Abdominal Wall Reconstruction
Recruiting NCT03255239 - Open Preperitoneal Mesh Versus Retromuscular Mesh Versus Suture Repair for Abdominal Wall Hernias N/A
Completed NCT03043079 - Ultrasound Assessment of Ventral Hernia Defects N/A
Completed NCT02129140 - Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)